Join us
Headquarters
USA

Verge Genomics

Verge is developing therapies for neurological diseases with a unique all-in-human platform. Advances in data from patients are rapidly promoting the understanding of the biology of diseases of the central nervous system, allowing for the identification of disease targets. Verge de-risks these targets in patient-derived neurons in the laboratory to generate small molecules, creating a pipeline of potential therapeutics in early development for many diseases, including ALS and Parkinson's.

Verge Genomics のウェブサイトを見る

メルマガの登録

グローバル・アジェンダのウィークリー・アップデート

© 2021 World Economic Forum

プライバシーポリシーと利用規約